Aztreonam | List of Frontiers open access articles

Original Research

Published on 24 Aug 2023

Aztreonam is a novel chemical inducer that promotes Agrobacteium transformation and lateral root development in soybean

in Microbe and Virus Interactions with Plants

M. Waqar Khan
Wenqi Yang
Ke Yu
Xuebin Zhang

Frontiers in Microbiology

doi 10.3389/fmicb.2023.1257270

3,645 views
3 citations

Original Research

Published on 16 Nov 2018

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii

in Infectious Agents and Disease

Mei-Ling Han
Xiaofen Liu
Tony Velkov
Yu-Wei Lin
Yan Zhu
Mengyao Li
Heidi H. Yu
Zhihui Zhou
Darren J. Creek
Jing Zhang

Frontiers in Microbiology

doi 10.3389/fmicb.2018.02776

6,231 views
17 citations

Case Report

Published on 03 Aug 2023

Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales

in Infectious Diseases: Pathogenesis and Therapy

Yanis Merad
Anne Conrad
Sophie Brosset
Axel Schmidt
Camille Hanriat
Sebastien Lustig
Frederic Laurent
Camille Kolenda
Tiphaine Roussel-Gaillard
Cecile Batailler

Frontiers in Medicine

doi 10.3389/fmed.2023.1224922

4,699 views
6 citations

Original Research

Published on 24 Jun 2021

A MexR Mutation Which Confers Aztreonam Resistance to Pseudomonas aeruginosa

in Antimicrobials, Resistance and Chemotherapy

Zhenzhen Ma
Congjuan Xu
Xinxin Zhang
Dan Wang
Xiaolei Pan
Huimin Liu
Guangbo Zhu
Fang Bai
Zhihui Cheng
Weihui Wu

Frontiers in Microbiology

doi 10.3389/fmicb.2021.659808

6,888 views
19 citations

Original Research

Published on 15 Dec 2025

Ceftazidime-avibactam for the treatment of multidrug-resistant or extensively drug-resistant bacteria infection in preterm infants: case series study and literature review

in Neonatology

Shiqi Guang
Tian Sang
Xifang Ru
Xin Zhang
Qi Feng
Ying Wang
Shan Li

Frontiers in Pediatrics

doi 10.3389/fped.2025.1723315

1,314 views

Original Research

Published on 05 Mar 2024

Activities of aztreonam in combination with several novel β-lactam-β-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae strains coproducing KPC and NDM

in Antimicrobials, Resistance and Chemotherapy

Xinhui Li
Jisheng Zhang
Jianmin Wang
Wenzhang Long
Xushan Liang
Yang Yang
Xue Gong
Jie Li
Longjin Liu
Xiaoli Zhang

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1210313

6,778 views
7 citations

Original Research

Published on 19 Jun 2025

Tracing the evolutionary trajectory of the IncP-2 plasmid co-harboring blaIMP-45 and blaVIM-1: an outbreak of Pseudomonas aeruginosa co-producing IMP-45 and VIM-1 carbapenemases in China

in Molecular Bacterial Pathogenesis

Yiqun Ma
Zichen Lei
Yulin Zhang
Qi Liu
Feilong Zhang
Hao Zu
Xinrui Yang
Ziyao Li
Binghuai Lu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1623241

2,453 views
3 citations

Systematic Review

Published on 04 Sep 2023

In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review

in Infectious Diseases: Pathogenesis and Therapy

Abdullah Tarık Aslan
Yukiko Ezure
Juan Pablo Horcajada
Patrick N. A. Harris
David L. Paterson

Frontiers in Medicine

doi 10.3389/fmed.2023.1249030

7,582 views
23 citations

Original Research

Published on 07 Apr 2021

Disbalancing Envelope Stress Responses as a Strategy for Sensitization of Escherichia coli to Antimicrobial Agents

in Antimicrobials, Resistance and Chemotherapy

Esther Recacha
Valeria Fox
Sara Díaz-Díaz
Ana García-Duque
Fernando Docobo-Pérez
Álvaro Pascual
José Manuel Rodríguez-Martínez

Frontiers in Microbiology

doi 10.3389/fmicb.2021.653479

4,523 views
10 citations

Original Research

Published on 30 May 2025

From genomics to treatment: overcoming pan-drug-resistant Klebsiella pneumoniae in clinical settings

in Pharmacology of Infectious Diseases

Fernando Pasteran
Juan Manuel De Mendieta
Natalia Pujato
Gina Dotta
Lisandro J. González
Mabel Rizzo
Alejandra Fernández
Paola Ceriana
Lucia Maccari
Melina Rapoport

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570278

4,024 views
1 citation

Original Research

Published on 03 Aug 2018

Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa

in Antimicrobials, Resistance and Chemotherapy

Vidya P. Narayanaswamy
Laura L. Keagy
Kathryn Duris
William Wiesmann
Allister J. Loughran
Stacy M. Townsend
Shenda Baker

Frontiers in Microbiology

doi 10.3389/fmicb.2018.01724

8,597 views
56 citations

Original Research

Published on 20 Mar 2025

Study on the invitro synergistic susceptibility and biofilm inhibition mechanism of ceftazidime-avibactam combined with aztreonam against carbapenem-resistant Klebsiella pneumoniae

in Antimicrobials, Resistance and Chemotherapy

Guangfen Wang
Hui Zhang
Qiaoping Wu
Jianqiang Xu
Xuedan Qiu
Jinyuan Chen
Fujie Cui
Jian Zhou
Qingcao Li

Frontiers in Microbiology

doi 10.3389/fmicb.2025.1542029

3,012 views
2 citations

Original Research

Published on 05 Apr 2024

Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

in Antimicrobials, Resistance and Chemotherapy

Natalia Słabisz
Patrycja Leśnik
Jarosław Janc
Miłosz Fidut
Marzenna Bartoszewicz
Ruth Dudek-Wicher
Urszula Nawrot

Frontiers in Microbiology

doi 10.3389/fmicb.2024.1331628

5,840 views
7 citations

Original Research

Published on 07 Oct 2020

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity

in Antimicrobials, Resistance and Chemotherapy

Eun-Jeong Yoon
You Jeong Choi
Sun Hee Park
Jeong Hwan Shin
Sung Gyun Park
Jong Rak Choi
Seok Hoon Jeong

Frontiers in Microbiology

doi 10.3389/fmicb.2020.561317

7,484 views
9 citations

Original Research

Published on 24 Oct 2025

Therapeutic challenges in managing Stenotrophomonas maltophilia bloodstream infection in a renal dysfunction patient: a case study and literature review

in Antibiotic Resistance and New Antimicrobial drugs

Xiongxiong Fan
Feng Chen
Zhengshang Ruan
Lixia Li

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2025.1694228

1,696 views

Brief Research Report

Accepted on 16 Feb 2026

High-dose aztreonam potentiates the combined antimicrobial activity of ceftazidime-avibactam against extensively drug-resistant New Delhi metallo-β-lactamase positive Pseudomonas aeruginosa in severe pneumonia treatment: the first global case report

in Clinical Infectious Diseases

Yifeng Liu
Cuiju Mo
Meng Li

Frontiers in Cellular and Infection Microbiology

Articles

Aztreonam is a novel chemical inducer that promotes Agrobacteium transformation and lateral root development in soybean

Metabolic Analyses Revealed Time-Dependent Synergistic Killing by Colistin and Aztreonam Combination Against Multidrug-Resistant Acinetobacter baumannii

Case report: Continuous infusions of ceftazidime-avibactam and aztreonam in combination through elastomeric infusors for 12 weeks for the treatment of bone and joint infections due to metallo-β-lactamase producing Enterobacterales

A MexR Mutation Which Confers Aztreonam Resistance to Pseudomonas aeruginosa

Ceftazidime-avibactam for the treatment of multidrug-resistant or extensively drug-resistant bacteria infection in preterm infants: case series study and literature review

Activities of aztreonam in combination with several novel β-lactam-β-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae strains coproducing KPC and NDM

Tracing the evolutionary trajectory of the IncP-2 plasmid co-harboring blaIMP-45 and blaVIM-1: an outbreak of Pseudomonas aeruginosa co-producing IMP-45 and VIM-1 carbapenemases in China

In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review

Disbalancing Envelope Stress Responses as a Strategy for Sensitization of Escherichia coli to Antimicrobial Agents

From genomics to treatment: overcoming pan-drug-resistant Klebsiella pneumoniae in clinical settings

Novel Glycopolymer Eradicates Antibiotic- and CCCP-Induced Persister Cells in Pseudomonas aeruginosa

Study on the invitro synergistic susceptibility and biofilm inhibition mechanism of ceftazidime-avibactam combined with aztreonam against carbapenem-resistant Klebsiella pneumoniae

Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

A Novel KPC Variant KPC-55 in Klebsiella pneumoniae ST307 of Reinforced Meropenem-Hydrolyzing Activity

Therapeutic challenges in managing Stenotrophomonas maltophilia bloodstream infection in a renal dysfunction patient: a case study and literature review

High-dose aztreonam potentiates the combined antimicrobial activity of ceftazidime-avibactam against extensively drug-resistant New Delhi metallo-β-lactamase positive Pseudomonas aeruginosa in severe pneumonia treatment: the first global case report